Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 17.50
+0.50 (2.94%)
Aug 15, 2025, 6:29 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 19.89 million as of August 15, 2025. Its market cap has increased by 572.79% in one year.
Market Cap
19.89M
Enterprise Value
19.48M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.50
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 19.89M, a decrease of -27.10%. That is a compound annual growth rate of -4.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.66B |
| GSK plc | 56.72B |
| Haleon | 32.11B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 2.01B |